AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.
from CBC | Health News https://ift.tt/34r1pIy
Aucun commentaire:
Enregistrer un commentaire